title: [Yellow fever: new recommendations].
abstract: Indication for yellow fever vaccination is not always easy to assess. The decision to immunize is not only based on the actual risk of the disease in a specific location, but also on public health considerations in the visited country (in order to respectively avoid epidemics in endemic countries or the introduction of the virus in zones where the vectors mosquitoes are present) and on travelers' risk factors for severe or even fatal vaccine adverse events. WHO has recently published new recommendations regarding vaccination against yellow fever after concluding that one dose of vaccine generates a life-long protection. This article tends to clarify the strategy to adopt in 2013 using cases frequently encountered in the practice of travel medicine.
authors.forename: L
authors.initials: L
authors.lastname: Rochat
authors.forename: B
authors.initials: B
authors.lastname: Genton
mesh_terms: D000328:Adult; D000349:Africa; D005260:Female; D006801:Humans; D008297:Male; D032541:Mass Vaccination / Q000592:standards; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D014195:Travel; D014944:World Health Organization; D015004:Yellow Fever / Q000517:prevention & control*; D022341:Yellow Fever Vaccine / Q000627:therapeutic use*
chemical_list: D022341:Yellow Fever Vaccine